FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Healthcare & Life Sciences Enterprise Capital Monitor – Europe 04/2024”.
The Monitor is a month-to-month revealed overview of enterprise capital tendencies within the European Healthcare & Life Sciences sector.
As of the top of April 2025 we recognized the next present VC tendencies in Europe:
- Whole Healthcare & Life Sciences funding reached EUR 4,297m (+32% vs. 2024)
- Biotech/Pharma acquired 32% of the overall funding quantity (EUR 1,388m) with metabolic problems (together with Diabetes, Weight problems) being the main indication (29%)
- In April, CMR Surgical (Belgium) secured the highest transaction quantity with EUR 185m, adopted by DeepUll (Spain) with EUR 45m and Sidekick Well being (Iceland) with EUR 42m
- GV (United States) is probably the most lively investor (by deal quantity in 2025), adopted by Alphabet (United States) and Thrive Capital (United States)
To entry the complete report, please click on right here.
By Mathias Klozenbücher and Johannes Hyperlink